— Know what they know.
Not Investment Advice

CTLT NYSE

Catalent, Inc.
1W: +2.0% 1M: +7.4% 3M: +5.2% 1Y: +53.0% 3Y: -48.1% 5Y: +21.6%
$63.48
Last traded 2024-12-17 — delisted
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · $11.5B mcap · 180M float · 1.24% daily turnover

Balance Sheet Trends

Total Assets
$9.8B -9.5% ▼
5Y CAGR: +9.5%
Total Liabilities
$6.1B +0.0% ▲
5Y CAGR: +6.4%
Shareholders Equity
$3.6B -22.2% ▼
5Y CAGR: +16.5%
Cash & Investments
$289M +3.2% ▲
5Y CAGR: -3.5%
Total Debt
$4.9B +1.4% ▲
5Y CAGR: +10.7%
Net Debt
$4.6B +1.3% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$953M$896M$449M$280M$289M
Short-Term Investments$0$71M$89M$0$0
Cash & ST Investments$953M$967M$538M$280M$289M
Net Receivables$918M$1.2B$1.5B$1.4B$1.6B
Inventory$324M$563M$702M$764M$574M
Other Current Assets$54M$77M$92M$66M$77M
Total Current Assets$2.3B$2.9B$2.9B$2.7B$2.6B
Property, Plant & Equip.$1.9B$2.5B$3.1B$3.7B$3.7B
Goodwill & Intangibles$3.4B$3.3B$4.1B$4.0B$3.2B
Long-Term Investments-$3.4B$38M$33M-$4.1B$47M
Other Non-Current Assets$3.6B$230M$316M$4.4B$208M
Total Non-Current Assets$5.5B$6.2B$7.6B$8.1B$7.2B
Total Assets$7.8B$9.1B$10.5B$10.8B$9.8B
— Liabilities —
Accounts Payable$321M$385M$421M$424M$361M
Short-Term Debt$73M$75M$31M$536M$48M
Deferred Revenue$191M$305M$185M$167M$250M
Other Current Liabilities$148M$201M$173M$188M$181M
Total Current Liabilities$893M$1.2B$1.1B$1.5B$1.0B
Long-Term Debt$2.8B$3.2B$4.2B$4.3B$4.9B
Other Non-Current Liab.$1.1B$312M$464M$247M$256M
Total Non-Current Liabilities$4.0B$4.0B$4.6B$4.6B$5.1B
Total Liabilities$4.9B$5.2B$5.7B$6.1B$6.1B
— Equity —
Common Stock$2M$2M$2M$2M$2M
Retained Earnings-$535M$25M$538M$262M-$781M
Accumulated OCI-$386M-$317M-$394M-$354M-$404M
Total Stockholders Equity$2.9B$3.9B$4.8B$4.6B$3.6B
Total Liabilities & Equity$7.8B$9.1B$10.5B$10.8B$9.8B
— Key Metrics —
Total Debt$3.0B$3.2B$4.2B$4.8B$4.9B
Net Debt$2.1B$2.3B$3.8B$4.6B$4.6B
Total Investments-$3.4B$109M$122M-$4.1B$47M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms